The Anti-Covid “Merck” Pill turns out as not very Effective

Society » HEALTH | November 26, 2021, Friday // 17:26
Bulgaria: The Anti-Covid “Merck” Pill turns out as not very Effective Pixabay

Updated data from the experimental pill for the treatment of COVID-19 by the American company Merck & Co show that its effectiveness is significantly lower than the original report. According to preliminary data from October, "molnupiravir" reduces the risk of death and hospitalization by 50%.

Now, in more than 1,400 patients - twice as many as in October - the risk is reduced by 30%. Following the announcement, the company's shares fell 3%, but this may include the effect on the stock exchanges of the news of the appearance of a mutated version of COVID-19 in South Africa.

Preliminary data showed hospitalization of 7.3% of those given the pill twice daily for 5 days and no deaths 29 days after treatment (in the placebo group, 14.1% were hospitalized). The updated data speak of 6.8% hospitalized and one deceased in the treated, as well as 9.7% hospitalized in the control group.


We need your support so can keep delivering news and information about Bulgaria! Thank you!

Health » Be a reporter: Write and send your article
Tags: Merck, pill, covid, effective
Advertisement All Are Welcome! Join Now!
Bulgaria news (Sofia News Agency - is unique with being a real time news provider in English that informs its readers about the latest Bulgarian news. The editorial staff also publishes a daily online newspaper "Sofia Morning News." (Sofia News Agency - and Sofia Morning News publish the latest economic, political and cultural news that take place in Bulgaria. Foreign media analysis on Bulgaria and World News in Brief are also part of the web site and the online newspaper. News Bulgaria